United States · FDA National Drug Code directory

Amlodipine Besylate

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71335-3126_2abdb000-40fa-48e8-8e70-c4ebd885d810
Product NDC
71335-3126
Form
TABLET
Composition / generic term
Amlodipine besylate
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
20251206
Source listing expiry
20271231

Source-listed ingredients

  • AMLODIPINE BESYLATE — 2.5 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET in 1 BOTTLE (71335-3126-1) · 71335-3126-1
  • 90 TABLET in 1 BOTTLE (71335-3126-2) · 71335-3126-2
  • 120 TABLET in 1 BOTTLE (71335-3126-3) · 71335-3126-3
  • 60 TABLET in 1 BOTTLE (71335-3126-4) · 71335-3126-4
  • 500 TABLET in 1 BOTTLE (71335-3126-5) · 71335-3126-5
  • 10 TABLET in 1 BOTTLE (71335-3126-6) · 71335-3126-6
  • 100 TABLET in 1 BOTTLE (71335-3126-7) · 71335-3126-7
  • 180 TABLET in 1 BOTTLE (71335-3126-8) · 71335-3126-8

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →